tm logo
SULINNO
REGISTERED

on 22 Feb 2023

Last Applicant/ Owned by

INNOVENT BIOLOGICS (SUZHOU) CO. LTD.

No. 168, Dongping Street, Suzhou Industrial Park,Suzhou CityJiangsu Province

CN

Serial Number

2067929 filed on 23rd Sep 2020

Registration Number

TMA1166842 registered on 22nd Feb 2023

Registration expiry Date

23rd Sep 2030

Correspondent Address

7450 rue Saint-HubertMontréal

QUEBEC

CA

H2R2N3

SULINNO

Vienna Information


5 . 5 . 18

Umbellate flowersFleurs disposées en ombelles

5 . 5 . 20

Stylized flowersFleurs stylisées

5 . 5 . 21

One flowerUne fleur

26 . 1 . 1

CirclesCercles

26 . 1 . 3

One circle or ellipseUn cercle ou une ellipse

26 . 1 . 15

Circles or ellipses containing representations of animals, parts of animals' bodies or plantsCercles ou ellipses contenant la représentation d'animaux, de parties du corps d'un animal ou de végétaux

26 . 1 . 24

Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée

5 . 5 . 19

Other flowers, blossoms -- Notes: (a) Including flowers or blossoms of trees (cherry trees, peach trees, apple trees) and of bushes. -- (b) Including flowers of protea and strelitzia.Autres fleurs -- Notes: (a) Y compris les fleurs d'arbres (cerisiers, pêchers, pommiers) et d'arbustes. -- (b) Y compris les fleurs de protea et de strelitzia.

26 . 1 . 26

Circles or ellipses with cutout areasCercles ou ellipses avec des zones découpées

Trademark usage description

pharmaceutical preparations for the treatment of gastrointestinal disorders; vaccines, namely human vaccines, veterinary vaccines; drugs for medical p Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of gastrointestinal disorders; vaccines, namely human vaccines, veterinary vaccines; drugs for medical purposes for the treatment of fever; biological preparations for medical purposes for the treatment of osteoporosis; medicines for human purposes for the treatment of tumors, ophthalmology diseases, cardiovascular diseases, autoimmune diseases and disorders, immunologic deficiency syndromes, anemia, anorexia, arthritis, bulimia nervosa, gout, hyperlipidemia, hypothyroidism, insulin resistance, metabolic syndrome, muscular dystrophy, obesity, osteoarthritis, blood disorders, diabetes, growth and thyroid disorders, primary periodic paralysis, glucagonoma, disorders relating to sexual reproduction and fertility, respiratory system diseases, central nervous system [CNS] diseases, cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies, plexopathies, genetic diseases; medicines for human purposes that modulate the immune system; medicines for human purposes for regulating the immune system; medicines for human purposes being antivirals; diagnostic preparations for medical laboratory use; diagnostic chemical reagents for medical purposes; medicinal solutions for injection for treating tuberculosis; liquid medicines for the treatment of tumors, ophthalmology diseases, cardiovascular diseases, autoimmune diseases and disorders, immunologic deficiency syndromes, anemia, anorexia, arthritis, bulimia nervosa, gout, hyperlipidemia, hypothyroidism, insulin resistance, metabolic syndrome, muscular dystrophy, obesity, osteoarthritis, blood disorders, diabetes, growth and thyroid disorders, primary periodic paralysis, glucagonoma, disorders relating to sexual reproduction and fertility, respiratory system diseases, central nervous system [CNS] diseases, cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies, plexopathies, genetic diseases; liquid medicines for human purposes that modulate the immune system; liquid medicines for human purposes for regulating the immune system; liquid medicines for human purposes being antivirals; biochemical medicines for the treatment of cancer; blood substitutes.


Classification kind code

11

Mark Details


Serial Number

2067929

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 13th Sep 2022
Agent Changed
Submitted for opposition 22
on 24th Mar 2022
Search Recorded
Submitted for opposition 20
on 24th Mar 2022
Examiner's First Report
Submitted for opposition 223
on 24th Mar 2022
Total Provisional Refusal
Submitted for opposition 256
on 04th Oct 2021
Notification of Possible Opposition Sent
Submitted for opposition 257
on 03rd Dec 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 02th Dec 2020
Formalized
Submitted for opposition 1
on 02th Dec 2020
Created
Submitted for opposition 228
on 23rd Sep 2020
International Registration
Submitted for opposition 30
on 23rd Sep 2020
Filed